Last updated on October 2018

Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)

Brief description of study

The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone compared with placebo in pediatric outpatients (7-17 years of age) with major depressive disorder.

Clinical Study Identifier: NCT02372799

Contact Investigators or Research Sites near you

Start Over

Clinical Trial Registries Team

Harmonex Neuroscience Research
Dothan, AL United States